Search for "ifnα 2023-2025新适应症" returned 15 results.

https://documentation.cochrane.org/wwirpt/revman-roadmap/1-revman-demos-q1-2025

" allowfullscreen></iframe> image-2025-6-13_8 … , including 1 guideline development tool. Date Reviews in long review format 2025-06-13 114 2025-05-02

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/q3q4-2024

development tool. Metrics image-2024-9-20_8-7-49.png Reviews in long review format 2025-01-10 … Sprint Review - 10 Jan 2025 Sprint focus 🎯 Sprint goal 1: Dynamic analysis results available in the Abstract

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2023q2

Sprint start date Description 24/04/2023 Q2 starts, generate main article and supplementary materials 08/05/2023 Enable supplementary materials, import of references, retire RevMan 5 22/05/2023 Enable supplementary

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/q42023

. Sprint start Sprint end Scope 20/11/2023 01/12/2023 Finish Angular migration 4/12/2023 15/12/2023 Install product analytics, Porto 18/12/2023 29/12/2023 Finish decision log, 🎄🎄🎄 Recordings folder

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2023q1

Sprint plan Sprint start Epic/backlog item 30/01/2023 Remove dependencies on RevMan 5 and RevMan 5 format/Supplementary materials 13/02/2023 Supplementary materials 27/02/2023 Supplementary materials 13/03

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/q32023

Sprint start Sprint end Scope 31/07/2023 11/08/2023 Focused review format 14/08/2023 25/08/2023 Focused review format 28/08/2023 08/09/2023 Study-centric data; Angular upgrade 11/09/2023 22/09/2023 Study

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2022q4-revman-web-development-progress

availability due to holidays 2023-01-05 Export and download, Non-Cochrane reviews phase II 2022-01-16 Move … last 30 days image-2023-1-27_8-19-54.png Reviews with advanced features in Cochrane (only use RevMan Web

https://documentation.cochrane.org/wwirpt/revman-roadmap/on-hold-not-yet-on-the-roadmap/support-more-types-of-study-centric-analyses

analyses/total number of analyses per review (for reviews started 2023) by end of 2023 is above 0.8. Which assumptions

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2023q2/improve-how-data-gets-into-revman-web-part-iii/improve-study-data-import

before April 2023. 3 author teams sign off on significantly improved user experience for transferring extracted data … on known information about the roadmap item and the capacity of the team at the time of estimation (2023-01-26).

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/q3q4-2024/update-statistical-methods-for-pairwise-meta-analysis

proportion of reviews using new method by end of 2023. Which assumptions are made in relation to the value? What

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2023q1/replace-revman-5-file-in-cochrane-library

RevMan 5 Hypothesis When RevMan 5 is retired in Apr 2023, the RevMan 5 files available in the Cochrane Library

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2023q2/changes-to-review-heading-structure-for-intervention-reviews

on known information about the roadmap item and the capacity of the team at the time of estimation (2023-01-26).

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2023q2/create-reviews-based-on-templates-without-using-revman-5-files

and the capacity of the team at the time of estimation (2023-01-26). Small = within 1 sprint = within 2 weeks.

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2023q2/introduce-supplementary-materials-part-2

of the team at the time of estimation (2023-01-26).

https://documentation.cochrane.org/wwirpt/revman-roadmap/previous-quarters/2023q1/introduce-supplementary-materials-part-1

of the team at the time of estimation (2023-01-26).